|
|
Volumn 174, Issue 9, 2006, Pages
|
|
Treatment with (R)-albuterol has no advantage over racemic albuterol.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
SALBUTAMOL;
ASTHMA;
CHEMISTRY;
COST OF ILLNESS;
DOSE RESPONSE;
ECONOMICS;
EDITORIAL;
HUMAN;
INHALATION TEST;
MORTALITY;
ADRENERGIC BETA-AGONISTS;
ALBUTEROL;
ASTHMA;
BRONCHIAL PROVOCATION TESTS;
COST OF ILLNESS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
|
|
EID: 33947325045
PISSN: 1073449X
EISSN: None
Source Type: Journal
DOI: 10.1164/rccm.2606003 Document Type: Editorial |
|
Times cited : (26)
|
|
References (0)
|
